Theme: Exploring Genetic Facts for Global Health

Genomics Meet 2017

Genomics Meet 2017

Conference series LLC is glad to invite you to attend 3rd Global Genomics and Toxicogenomics Meeting, during September 21-22, 2017 Toronto, Canada. Genomics Meet-2017 includes Keynote presentations, Oral talks and Poster presentation. Conference is organised with the theme ‘’Exploring Genetic Facts for Global Health’’ which contains 14 Tracks to shape the theme of the conference.

Track 1: Genomics

Genomics is study of entirety of an organism's genome .Genome includes all the genes of an organism taken together plus all of the sequences and information confined therein. Genomics is a much newer field than genetics and became possible only in the former couple of decades due to technical advances in DNA sequencing and computational biology Using High-performance computing and math practices known as Bioinformatics, genomics researchers analyse  enormous amounts of DNA-sequence data to find variants that affect health, disease or drug response.

Track 2: Human Genetics

Human genetics it is the discipline of genetic technology where study of inheritance occurs in human beings is done. Human genetics comprises a variety of overlapping fields like Genetic counselling, Genomics, Bioinformatics, Immunogenetics. Genes is the most common factor of qualities of human-inherited trait. Human genetic study can be useful as it answers about human nature, development of effective disease treatment and understand genetics of human life.

Track 3: Oncogenomics

Oncogenomics is a sub-branch of genomics. Oncogenomics is study of cancer-associated mainly focuses on Genomic, Epigenomic and Transcript Alterations. Scientists have sequenced the human genome and identified most of its genes. This genomic data is used to tackle the major health problems like cancer. Cancer is caused by accumulation of DNA mutations and epigenetic alterations leading to cell proliferation and neoplasm formation. The main goal of oncogenomics is cancer diagnosis and therapy. This can be done by identifying new tumor suppressor gene or oncogene.

Track 4: Medical Genetics

Medical genetics is the discipline of medicine that involves the diagnosis and management of Hereditary Disorders. Medical genetics states the application of genetics to medical care. It differs from human genetics which is a field of scientific research that may or may not relate to medicine. Medical genetics encompasses many different areas, including Clinical Genetics, Gene Therapy, Cytogenetics, Molecular Genetics.

Track 5: Ecogenomics

Ecogenomics is a field which deals with the application of advanced molecular technologies to study organismal response to environmental challenges in respective nature. This area studies the structure and function of nucleotide sequence isolated directly from environmental sample which is also termed as Metagenomics. Ecogenomics also covers fields like Microbial Genomics, Plant Genomics, Agrigenomics.

Track 6: Genome Analysis

Genomic analysis is the identification and measurement of genomic features. DNA sequences, structural variation, gene expression are identified, measured or compared at a genomic scale. Analysis of genome requires typically High-Throughtput Sequencing or Microarray Hybridization Techniques. For analysis DNA is first sequenced, assembled, annotated and analysed. For genomic analysis few tool kits are also avalaible now. Many analysis like family-based analysis or case-control analysis can be done

Track 7: Genomics in Drug Development

Genomics, mainly Next Generation Sequencing (NGS) enables all the researchers and drug developers to understand completely the biology of the genome that drives many diseases and disorders. NGS mainly helpful for diseases like cancer. Genomics have led to development of Multi-Analyte Tumor Analysis and Targeted Therapeutics. Knowledge of human gene and their function may allow for drug discovery development process.

Track 8: Genome Informatics

Genome informatics is the branch of genomics in which statistical and computer techniques are applied to obtain biological information from genome sequence. Genome informatics includes several methods to analyse DNA sequence and to predict the protein sequence and structure. Informatics mainly involves the Identification of candidate genes and nucleotides for proper understanding of genetic basis of disease. It plays a role in the analysis of gene and protein expression and regulation.

Track 9: Application of Genomics

Next-Generation Sequencing technologies allow biomedical researchers and clinicians to increase the amount of genomic data collected on large study populations. Genomics allows the researchers to understand completely the genetic basis of drug response and disease. Genomics can be applied in many fields, including Synthetic Biology, Medicine Biotechnology, Social Sciences.

Track 10: Genetic Toxicology

Genetic toxicology is the scientific branch which deals with the effects of physical, chemical and biological agents on the genome or heredity of living organisms. Toxic effects alter DNA directly or indirectly by induction of mutation, mistimed event activation and DNA damage. Genotoxicity can be tested by Ames Test, Micronucleus Test, SOS Test, COMET Test. Genetic toxicology testing can help narrow down the list of potential candidates by eliminating drugs that have a high cancer-causing potential.

Track 11: Toxicogenomics

Toxicogenomics is the branch of science dealing with the collection, interpretation and storage of information about protein and gene activity within the cell or tissue of an organism in response to toxic agents. Studying these mechanisms can aid in building better animal and human models, with the goal of better predicting toxic response in humans. The field of “toxicogenomics” relate global mRNA, protein and metabolite analysis related technologies to study the effects of hazards on organisms.

Track 12: Toxicogenomics Challenges & Applications

A major challenge facing investigators is to devise large-scale, high-throughput procedures for genotyping and phenotyping polymorphisms of pharmacogenetic interest as well as better ways to use this knowledge to develop risk profiles describing individual susceptibility to drugs. Toxicogenomics promises to facilitate research into toxicant mechanisms, with the opportunity of assisting in the detection of compounds with the potential to cause adverse health effects earlier in the development of pharmaceutical and chemical products.

Track 13: Pharmacogenomics

Pharmacogenomics is the research on genetic variability that influences individual response to drugs. Prescriber can individualize drug therapy by knowing patient’s genetic variation if any and can decrease chance for adverse drug reactions. Pharmaceutical companies will be able to create therapies more targeted to specific diseases, maximizing therapeutic effects while decreasing harm to nearby healthy cells. The most common variations in the human genome are called Single Nucleotide Polymorphisms.

Track 14: Omics Techniques and Their Application to Genomics

OMICS technology is relatively new biomarker discovery tool that can be applied to study large sets of biological molecules. Due to spectacular increase in the sensitivity, resolution and throughput of OMICS based assays its application in human observational studies has become feasible. The five most developed OMICS technologies are Genotyping, Transcriptomics, Epigenomics, Proteomics and Metabolomics.

Organising successful conferences has been at the core of Conference Series LLC. We are delighted to organize the 3rd Global Genomics and Toxicogenomics Meeting during September 21-22, 2017 at Toronto, Canada. This global event mainly focuses on “Exploring Genetic Facts for Global Health.”

Genomics Meet 2017 offers a unique platform to present and know the latest updates with a complete approach to diverse areas of interest.  Genomics is a discipline in genetics that concerns the sequencing and analysis of an organism’s genome. Genomics emphases on interactions between loci and alleles within the genome and also intragenomic processes such as epistasis, pleiotropy and heterosis. The fields of molecular biology and genetics are major topics in today’s biomedical research which are mainly concerned with the study of the role and function of single genes. Whereas, genomics does not involve single gene research unless the objective is to understand a single gene’s effects in connection of the entire genome. Toxicogenomics deals with the collecting, interpreting, and storing of data about gene and protein activity in order to detect toxic substances in the environment, and to help treat individuals at the greatest risk of diseases caused by environmental pollutants or toxicants.

Conference Series LLC organizes a conference series of 1000+ Global Events inclusive of 300+ Conferences, 500+ Upcoming and Previous Symposiums and Workshops in USA, Europe & Asia with support from 1000 more scientific societies and publishes 700+ Open access journals which contains over 30000 eminent personalities, reputed scientists as editorial board members.

Why Genomics Meet 2017??

At Genomics Meet 2017 you can meet the world leading Geneticists, clinical research professionals, biochemists and also the industrialists who will provide you with the latest innovations and scientific approaches thus help you in widening your scientific knowledge.

The topics of the Conference will reflect the recent advances, current trends, future trends and new approaches in Genomics. This conference covers all the major topics that come across like Toxicogenomics, Genomic Medicine, Pharmacogenomics, Medical Genetics, Human Genetics, Cancer genomics, Medical Genetics and a broad scope of Genomics in different fields.

Thus, our objective is, to create platforms which will gather eminent scientists who will undoubtedly enrich our conference during the Q&A sections.

Target Audience:

  • Academicians including Professors
  • PhD Scholars
  • Students carrying out laboratory and field studies
  • Genetic Professionals
  • Genetics Associations and Societies
  • Pathology Professionals
  • Forensic Professionals
  • Pharmaceutical companies
  • Clinical Laboratories and Technicians 
  • Bio-informatics Professionals
  • Research Institutes and members
  • Pharmaceutical Industrial Giants
  • Nobel laureates in Health Care and Medicine
  • Pharmacists
  • Physicians
  • Pharmacologists
  • Toxicology Professionals
  • Supply Chain companies
  • Manufacturing Companies
  • Training Institutes
  • Business Entrepreneurs


Omics International invites all the participates  across the globe to attend 3rd Global Genomics and Toxicogenomics Meeting, September 21-22, 2017 Toronto, Canada which includes prompt keynote presentations, Oral talks, Poster presentations. The main theme of the conference is ‘Exploring Genetic Facts for Global Health” which covers a wide range of key sessions.

Importance & Scope:

Genomics is the branch of genetics deals with the sequencing and analysis of genome of an organism. Genomics highlights connections between loci and alleles within the genome and also intragenomic processes such as epistasis, pleiotropy and heterosis.  Genomics can explain the causes of and responses to common chronic diseases that affect so much of the population: diseases like cardiovascular disease, diabetes, various forms of cancer. Genetic knowledge was used not only to benefit individual patients, but to whole populations.

Genomics may bring new and deeper understanding of significant problems in medicine, science, and public health. Ecogenetics a discipline of genomics has a long overdue role in occupational, environmental, and regulatory decision making. Identification of the genes liable for human mendelian diseases, once a herculean task can now be routinely done in a few weeks by a single graduate with access to DNA samples.

The scientific meet of Genomics Meet 2017 encloses informational sessions, panel discussions, regional sessions, and poster sessions. Genomics Meet 2017 enhances chance to exchange the knowledge in genomics and toxicogenomics.

Why Toronto?

The Centre for Applied Genomics is a genome centre in Toronto, Canada. It is affiliated with University of Toronto. This centre focuses on the genetic and genomic basis of human variability, health and disease, including research on the genetics of autism spectrum disorder and structural dissimilarity of the human genome. Major universities in Canada also work upon several disciplines of Genomics and Toxicogenomics. Associations like International Genetic Epidemology Society, American Society of Human Genetics (ASHG) etc. conducting research works making Toronto a well advised location for conference.

Conference Highlights:

  • Ecogenomics
  • Human Genetics
  • Genomics
  • Oncogenomics
  • Genome Analysis
  • Medical Genetics
  • Applications of Genomics
  • Genome Informatics
  • Genomics in Drug Development
  • Genetic Toxicology
  • Pharmacogenomics
  • Toxicogenomics
  • Toxicogenomics Challenges & Applications
  • Omics Techniques and their Application to Genomics

Major Associations around the Globe:

  • Environmental Mutagenesis and Genomics Society
  • American association for the advancement of science
  • American association for cancer research
  • American cancer society
  • Human Genome Mapping Project, UK
  • Worldwide genetic resources, Japan      
  • Genome Center, Cold Spring Harbor, NY
  • Biotechnology information system network, India
  • Genoscope
  • Japan Science and Technology Corporation
  • Genome therapeutic corporation

Major Associations in USA:

  • National center for genome resources, USA
  • National human genome research institute, USA
  • National human genome research institute, USA
  • Food and drug administration, USA
  • Lawrence Berkeley Laboratory, California, USA
  • Lawrence Livermore National Laboratory, California, USA
  • Centers for disease control and prevention, USA
  • Department of health and human services, USA
  • Oak ridge national laboratory, USA

Target Audience:

  • Academicians including Professors
  • PhD Scholars
  • Students carrying out laboratory and field studies
  • Genetic Professionals
  • Genetics Associations and Societies
  • Pathology Professionals
  • Forensic Professionals
  • Pharmaceutical companies
  • Clinical Laboratories and Technicians
  • Bio-informatics Professionals
  • Research Institutes and members
  • Pharmaceutical Industrial Giants
  • Nobel laureates in Health Care and Medicine
  • Pharmacists
  • Physicians
  • Pharmacologists
  • Toxicology Professionals
  • Supply Chain companies
  • Manufacturing Companies
  • Training Institutes
  • Business Entrepreneurs

Top Universities in USA:

  • Auburn University
  • Samford University
  • Midwestern University
  • The University of Arizona
  • Harding University
  • University of Arkansas for Medical Sciences
  • California Health Sciences University
  • Keck Graduate Institute
  • The University of Kansas
  • National institute of diabetes, digestive and kidney diseases, USA
  • National institute of mental health, USA
  • National institute of neurological disorders and stroke, USA
  • Centre for genetics in medicine, Washington university

Statistical analysis of Universities:


Top Genomics Companies:

  • Abbott laboratories
  • AutoGenomics
  • Biocartis
  • Bio-Rad Laboratories
  • Cepheid
  • Elitech groups
  • IntegraGen
  • Myraid Genetics
  • Perkin Elmer
  • Qiagen
  • WaferGen Biosystems, Inc.
  • GeneWorks

Glance at the Market:

Genomics is discipline of biology that is concerned with the study of genes. In 2013, genomics-based diagnostics held the major share of market revenue at over 35% on account of the occurrence of a considerably larger number of research & development initiatives. The global genomics market is self-assured to reach USD 19.99 Billion by 2020, growing CAGR of 9.9% through the forecast period of 2015 to 2020.

The growth of genomics market is influenced by many factors such as increasing research in the field of genomics; increasing number of start-up companies; and growing application of genomic sequencing in the diagnostics, increasing investments, grants, and funds by the government. In the coming years, the market is supposed to witness the highest growth rate in the North American which can be credited to the enactment of Personalized Medicine Initiative in 2015.

The global genomics market was segmented on the basis of product, technology, application, and region.

In 2015 based on products, the consumables accounted for the larger share of the genomics market and estimated to grow at the fastest rate during the forecast period. This is attributed to factors such repeated use of consumables for the genomic experiments, increasing research programs by academic institutes

The market of technology was segmented into PCR, nucleic acid extraction & purification, microarray technology, sequencing, branched DNA (b DNA) technology. In 2013, PCR technology had the largest market share of over 45% owing to technological developments. Nucleic acid extraction and purification technology are supposed to witness the highest growth rate, at a projected CAGR of 10.1%, from 2015 to 2020

Based on the various application areas of genomics, the market is segmented into diagnostics, drug discovery & drug development, personalized medicine, and agriculture & animal research. The research centres, academic institutes, and government centre segment accounted for the largest share of the market, by end user, in 2015. This largest share is credited to the increasing research initiatives and projects in the area of genomics worldwide.

With the major decrease in the sequencing costs and rising investments in the pharmaceutical industry, the global genomics market is forecast to grow at a CAGR of 9.9% during the forecast period of 2015 to 2020.


Drug Monitoring 2016

Drug Monitoring 2016 Report

The 2nd International Conference on Clinical Trials and Therapeutic Drug Monitoring, hosted by the Conferenceseries LLC was held during August 22-24, 2016 at Philadelphia, Pennsylvania, USA based on the theme Discoveries and Developments for Safer Medication”. Benevolent response and active participation was received from the Organizing Committee Members as well as from the Scientists, Researchers, Students and leaders from various fields of Clinical Research & Trials, Biotech, Toxicology, Medical and pharmacy, who made this event a wonderful success.

Drug Monitoring 2016 marked its start by an opening ceremony which included introduction by the Honorable Guests and the Members of Keynote Forum. We thank all our magnificent Keynote Speakers, Speakers, Conference Attendees, Students, Honorable guests, Media Partners, Associations, Sponsors and Exhibitors for making our Conference a grand success.

Conferenceseries LLC expresses its gratitude to the conference Moderators, namely DAnvita Karara and Elena Landoni for taking up the responsibility to coordinate during the sessions. We also extend our appreciation towards our Chairs and Co-Chairs of the sessions for 3 days, namely Entsuah Anthony Richard, Suyu Liu, Ayad K Abdul-Ahad, Joao Paulo Tardivo and Nicola Stagg.

The conference was initiated with the Honorable presence of the Keynote forum. The list includes:

  • Michael BernsteinClinical Supplies Management, Inc., USA
  • Jody Ehrhardt, Ehrhardt Clinical Research, USA
  • Stephen Hsu, Augusta University, USA
  • Tamera N Smith, Norton Audits, Inc., USA
  • Jill McNair, CISCRP, USA
  • Thomas E Serena, SerenaGroup, USA

The meeting reflected various sessions, in which discussions were held on the following major scientific tracks:

  • Pre-Clinical Research and Conducts of Clinical Trials
  • Innovations  and Future of Clinical Trials
  • Clinical Data Management and Statistics
  • Clinical Research and Trials on Diabetes/ AIDS / Cancer
  • Clinical Trials on different Diseases and Medical Devices
  • Clinical Trials (Countries/Continents)
  • Clinical Trial Supply Management
  • Therapeutic Drug Monitoring and Drug Quantification
  • Pharmacovigilance and Drug Safety

Conference Series LLC offers its heartfelt appreciation to organizations such as The Pharma Review, BioTech Pharm Jobs, Event listing sites of Philadelphia and other eminent personalities who supported the conference by promoting in various modes online and offline which helped the conference reach every nook and corner of the globe. 

With the grand success of Drug Monitoring 2016Conference Series LLC is proud to announce the 3rd Global Genomics and Toxicogenomics Meeting” September 21-22, 2017 Toronto, Canada.

For More details visit:

Let us meet again @ Genomics Meet 2017

Past Reports  Gallery  

Toxicogenomics 2015
Toxicogenomics 2015 Report

International Conference on Toxicogenomics and Drug Monitoring was held in Valencia, Spain during August 25-27, 2015. OMICS International has provided a platform to frame the conference on “Discoveries in Prediction of Toxicity and Drug Monitoring” which served as an excellent opportunity to gain new knowledge, share technical and pharmaceutical experiences, networking with colleagues and communicate with industry partners.

Toxicogenomics 2015 would like to thank the ModeratorDr. Farhad Kamali, Newcastle University, UK for extending warm support for smooth functioning of the conference.

It was our pleasure to have Dr. Susana Garcia de Arriba, Schaper & Brummer GmbH & Co. KG, Germany to organize a workshop on “Human safety of free hydroquinone derived from herbal medicinal products containing Uvae ursi folium”.

The event witnessed vivacious speeches from Keynote Speakers, Scientists, Researchers, and many other participants targeting diverse areas of Toxicogenomics and Drug Monitoring emphasizing the below scientific tracks:

  • Toxicology Approaches
  • Concept of Toxicogenomics
  • Omics Technologies in Toxicogenomics
  • Biomarkers in Toxicogenomics
  • Drug Monitoring
  • Predictive Human Toxicity and ADME/Tox Studies
  • Genomics Approaches to Predictive Toxicology
  • PK and PD Tools for DNA-Damage Pathways
  • Adverse Outcome Pathways
  • Bioinformatics in Toxicogenomics
  • Environmental Toxicogenomics
  • Animal Modeling in Toxicogenomics and Toxicoproteomics
  • Comparative Toxicogenomics

The conference commenced successfully with the vehement presentations by Eminent Speakers like

Jenny Bosson, Umea University, Sweden

Wilhelm Gaus, University of Ulm, Germany

D Weissmann, Alcediag, France

Raúl Bonne Hernández, Federal University of São Paulo, Brazil

Dinora Vázquez-Luna, Universidad Veracruzana, Mexico

Wafa Soudani, Annaba Medical College, Algeria

Eman Alaaeldin Adbelfattah, Cairo University, Egypt

Gazo I, University of South Bohemia in Ceske Budejovice, Czech Republic

OMICS International, on behalf of the Conference, congratulates all the speakers for their outstanding performance in the field and wishes them success in future endeavors. We would like to thank all the participants for their flamboyant presence and enlivened presentations.

Following on the heels of this successful event, we are excited to announce 2ndInternational Conference on Therapeutic Drug Monitoring and Toxicogenomics to be held during August 25-26, 2016 in Philadelphia, USA and wish that your overwhelming support will make Drug Monitoring 2016 an outstanding event.

Past Reports  Gallery  

Click here to submit abstract to any of the above topics


Want to Differentiate your company from your competitors and broaden your competitive edge?

Use our global platform of 3000+ Global Events

  • 25 Million+ Visitors to our Global website (
  • 20000+ Unique Visitors per conference
  • 60000+ Page views per conference

For customized sponsorship opportunities at our conferences, or to place an ad on our websites, contact at or call at: +1-650-268-9744

To share your views and research, please click here to register for the Conference.

To Collaborate Scientific Professionals around the World

Conference Date September 21-22, 2017
Sponsors & Exhibitors Click here for Sponsorship Opportunities
Speaker Opportunity
Poster Opportunity Available

Conferenceseries Destinations